These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2880620)

  • 41. Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.
    Amos RS; Pullar T; Bax DE; Situnayake D; Capell HA; McConkey B
    Br Med J (Clin Res Ed); 1986 Aug; 293(6544):420-3. PubMed ID: 2874863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis.
    Delamere JP; Farr M; Grindulis KA
    Br Med J (Clin Res Ed); 1983 May; 286(6377):1547-8. PubMed ID: 6133577
    [No Abstract]   [Full Text] [Related]  

  • 43. Hypogammaglobulinaemia and thrombocytopenia associated with sulphasalazine therapy in rheumatoid arthritis.
    Farr M; Tunn E; Bacon PA; Smith DH
    Ann Rheum Dis; 1985 Oct; 44(10):723-4. PubMed ID: 2864899
    [No Abstract]   [Full Text] [Related]  

  • 44. Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis.
    Narayan N; Rigby S; Carlucci F
    Clin Rheumatol; 2017 Feb; 36(2):477-479. PubMed ID: 27778097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.
    Wijnands MJ; Van 'T Hof MA; Van De Putte LB; Van Riel PL
    Br J Rheumatol; 1993 Apr; 32(4):313-8. PubMed ID: 8096419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sulphasalazine hepatotoxicity: lack of a hypersensitivity response.
    MacGilchrist AJ; Hunter JA
    Ann Rheum Dis; 1986 Nov; 45(11):967-8. PubMed ID: 2878646
    [No Abstract]   [Full Text] [Related]  

  • 48. Acetylation, sulphasalazine and its effects.
    Astbury C; Taggart AJ
    Br J Rheumatol; 1987 Jun; 26(3):229-30. PubMed ID: 2884010
    [No Abstract]   [Full Text] [Related]  

  • 49. Leucopenia during sulphasalazine treatment for rheumatoid arthritis.
    Marabani M; Madhok R; Capell HA; Hunter JA
    Ann Rheum Dis; 1989 Jun; 48(6):505-7. PubMed ID: 2568110
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ANAEMIA IN RHEUMATOID ARTHRITIS.
    AGARWAL RL; INSAF HA; AGARWAL V
    Indian Pract; 1965 Jun; 18():419-23. PubMed ID: 14333264
    [No Abstract]   [Full Text] [Related]  

  • 51. Anaemia in rheumatoid arthritis.
    Br Med J; 1969 Mar; 1(5645):659-60. PubMed ID: 5774309
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experiences in long-term therapy of rheumatoid arthritis with sulfasalazine tablets].
    Amos RS
    Z Rheumatol; 1987; 46(2):76-8. PubMed ID: 2885988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results.
    Georgescu C
    Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical efficacy of sulphasalazine in rheumatic disease.
    Taggart AJ
    Agents Actions Suppl; 1988; 24():189-96. PubMed ID: 2903619
    [No Abstract]   [Full Text] [Related]  

  • 55. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome.
    Shenoy P; Misra R; Jain M; Agarwal V
    N Z Med J; 2008 Jun; 121(1276):102-5. PubMed ID: 18574514
    [No Abstract]   [Full Text] [Related]  

  • 57. Should tests for proteinuria be included in the monitoring schedule of sulphasalazine?
    Helliwell PS
    Br J Rheumatol; 1995 Aug; 34(8):790-1. PubMed ID: 7551669
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Sulfasalazine: side effects and duration of therapy in patients with rheumatoid arthritis].
    Mundo A; Pedone V; Lamanna G; Cervini C
    Clin Ter; 1997; 148(1-2):7-13. PubMed ID: 9377840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulphasalazine induced autoimmune syndrome.
    Vyse T; So AK
    Br J Rheumatol; 1992 Feb; 31(2):115-6. PubMed ID: 1346581
    [No Abstract]   [Full Text] [Related]  

  • 60. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.